Aims: To select a core list of standard outcomes for diabetes to be routinely applied internationally, including patient-reported outcomes. Methods: We conducted a structured systematic review of outcome measures, focusing on adults with either type 1 or type 2 diabetes. This process was followed by a consensus-driven modified Delphi panel, including a multidisciplinary group of academics, health professionals and people with diabetes. External feedback to validate the set of outcome measures was sought from people with diabetes and health professionals. Results: The panel identified an essential set of clinical outcomes related to diabetes control, acute events, chronic complications, health service utilisation, and survival that can be me...
Background: Type 2 diabetes is characterised by abnormal glucose metabolism, and treatment is aimed ...
BACKGROUND:Type 2 diabetes is characterised by abnormal glucose metabolism, and treatment is aimed a...
Objectives Heterogeneity in outcomes measured across trials of glucose-lowering interventions for ...
Aims: To select a core list of standard outcomes for diabetes to be routinely applied internationall...
Aims: To select a core list of standard outcomes for diabetes to be routinely applied internationall...
This is an updated preprint of our Delphi study to develop a person-centered outcome set for routine...
Collecting patient-reported outcomes (PROs) in a standardised way and integrating them with clinical...
This is a pre-print of our Delphi study to develop a person-centered outcome set for routine diabete...
Background: Achieving consensus from a range of relevant stakeholders about an agreed set of core ou...
Objectives: The aims of the present systematic review were to identify currently available patient-r...
Pre-print of a systematic literature review to identify candidate patient reported outcomes with pot...
Systematic literature review to identify candidate patient reported outcomes with potential to infor...
Objective: We aimed to investigate willingness to complete patient-reported outcome measures (PROMs)...
Abstract Background Type 2 diabetes is characterised by abnormal glucose metabolism, and treatment i...
Type 2 diabetes is characterised by abnormal glucose metabolism, and treatment is aimed at normalisi...
Background: Type 2 diabetes is characterised by abnormal glucose metabolism, and treatment is aimed ...
BACKGROUND:Type 2 diabetes is characterised by abnormal glucose metabolism, and treatment is aimed a...
Objectives Heterogeneity in outcomes measured across trials of glucose-lowering interventions for ...
Aims: To select a core list of standard outcomes for diabetes to be routinely applied internationall...
Aims: To select a core list of standard outcomes for diabetes to be routinely applied internationall...
This is an updated preprint of our Delphi study to develop a person-centered outcome set for routine...
Collecting patient-reported outcomes (PROs) in a standardised way and integrating them with clinical...
This is a pre-print of our Delphi study to develop a person-centered outcome set for routine diabete...
Background: Achieving consensus from a range of relevant stakeholders about an agreed set of core ou...
Objectives: The aims of the present systematic review were to identify currently available patient-r...
Pre-print of a systematic literature review to identify candidate patient reported outcomes with pot...
Systematic literature review to identify candidate patient reported outcomes with potential to infor...
Objective: We aimed to investigate willingness to complete patient-reported outcome measures (PROMs)...
Abstract Background Type 2 diabetes is characterised by abnormal glucose metabolism, and treatment i...
Type 2 diabetes is characterised by abnormal glucose metabolism, and treatment is aimed at normalisi...
Background: Type 2 diabetes is characterised by abnormal glucose metabolism, and treatment is aimed ...
BACKGROUND:Type 2 diabetes is characterised by abnormal glucose metabolism, and treatment is aimed a...
Objectives Heterogeneity in outcomes measured across trials of glucose-lowering interventions for ...